Patrick Gleason of Prime Therapeutics on Pharmacogenomic Testing

Video

Patrick Gleason, PharmD, BCPS, FCCP, director of Health Outcomes at Prime Therapeutics, discusses the value of pharmacogenomic testing and the factors that influence whether a health plan or PBM will reimburse for the use of that test.

Patrick Gleason, PharmD, BCPS, FCCP, director of Health Outcomes at Prime Therapeutics, discusses the value of pharmacogenomic testing and the factors that influence whether a health plan or PBM will reimburse for the use of that test.

Related Videos
Young depressed woman talking to lady psychologist during session, mental health - Image credit: motortion | stock.adobe.com
man taking opioid pills sitting at a dark table - Image credit: rohane | stock.adobe.com
schizophrenic man - mental disorder - Image credit: Andreza | stock.adobe.com
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Image credit: motortion | stock.adobe.com - Young depressed woman talking to lady psychologist during session, mental health
Image credit: Sergey | stock.adobe.com - Unhappy woman with insomnia lying on bed next to alarm clock at night
Image credit: Chanintorn.v | stock.adobe.com - PTSD Mental health concept, Psychologist sitting and touch hand young depressed asian man for encouragement near window with low light environment.Selective focus.
Image credit: JPC-PROD | stock.adobe.com - Choosing method of contraception : Birth control pills, an injection syringe, condom, IUD-method, on grey
Related Content
woman holding hands near head while suffering from headache in bedroom | Image Credit: LIGHTFIELD STUDIOS - stock.adobe.com

Migraine Treatment Comes in Different Forms, Allowing for Patient Preference

April 23rd 2024
Article
Pharmacy Focus: Policy Edition - Discussing the DRUG Act and PBM Reform

Pharmacy Focus: Policy Edition - Discussing the DRUG Act and PBM Reform

April 5th 2024
Podcast
nerve cells, Neurologic Disease, tumors,brain surgery | Image Credit: ralwel - stock.adobe.com

Study: Ofatumumab Shows Efficacy Up to 6 Years for Multiple Sclerosis

April 23rd 2024
Article
Pharmacy Focus: OTC Contraception and Reproductive Health

Pharmacy Focus: OTC Contraception and Reproductive Health

March 29th 2024
Podcast
nerve cells, Neurologic Disease, tumors, brain surgery | Image Credit: ralwel - stock.adobe.com

Ocrelizumab Demonstrates Near-Complete Suppression of Relapses for Multiple Sclerosis

April 22nd 2024
Article
Man sleeping in bed wearing CPAP mask | Image Credit: sbw19 - stock.adobe.com

Tirzepatide Demonstrates Reduction in Sleep Apnea-Relate Events

April 18th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.